-
EP0760649
European procedure
Extract from the Register of European Patents
EP About this file: EP0760649
| EP0760649 - FLUTICASONE PROPIONATE FORMULATIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 06.09.2002 Database last updated on 06.07.2024 | Most recent event Tooltip | 06.09.2002 | No opposition filed within time limit | published on 23.10.2002 [2002/43] | Applicant(s) | For all designated states GLAXO WELLCOME AUSTRALIA LTD. 1061 Mountain Highway Boronia, VIC 3155 / AU | [1997/11] | Inventor(s) | 01 /
TAINSH, David, Alexander Glaxo Research and Development Limited Park Road, Ware Hertfordshire SG12 0DP / GB | 02 /
ILOTT, Trevor, Leslie Glaxo Research and Development Limited Park Road Ware Hertfordshire SG12 0DP / GB | 03 /
SNELL, Dorothy, Jill Glaxo Australia Pty. Limited 1061 Mountain Highway Boronia, VIC 3155 / AU | 04 /
LAM, Li, Fong Glaxo Australia Pty. Limited 1061 Mountain Highway Boronia, VIC 3155 / AU | [1997/11] | Representative(s) | Priestley, Ruth Elizabeth, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [1997/11] | Hackett, Ruth Elizabeth, et al Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | Application number, filing date | 95920841.4 | 19.05.1995 | [1997/11] | WO1995EP01913 | Priority number, date | GB19940010222 | 21.05.1994 Original published format: GB 9410222 | [1997/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9531964 | Date: | 30.11.1995 | Language: | EN | [1995/51] | Type: | A1 Application with search report | No.: | EP0760649 | Date: | 12.03.1997 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.11.1995 takes the place of the publication of the European patent application. | [1997/11] | Type: | B1 Patent specification | No.: | EP0760649 | Date: | 31.10.2001 | Language: | EN | [2001/44] | Search report(s) | International search report - published on: | EP | 30.11.1995 | Classification | IPC: | A61K9/00, A61K31/56 | [1997/11] | CPC: |
A61K9/0078 (EP,US);
A61K9/14 (KR);
A61K31/56 (EP,US);
A61K47/02 (KR);
A61K47/26 (KR);
A61P11/06 (EP)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/11] | Extension states | LT | 04.11.1996 | LV | 04.11.1996 | SI | 04.11.1996 | Title | German: | FLUTICASONPROPIONAT-FORMULIERUNGEN | [1997/11] | English: | FLUTICASONE PROPIONATE FORMULATIONS | [1997/11] | French: | FORMULATIONS A BASE DE PROPIONATE DE FLUTICASONE | [1997/11] | Entry into regional phase | 04.11.1996 | National basic fee paid | 04.11.1996 | Designation fee(s) paid | 04.11.1996 | Examination fee paid | Examination procedure | 30.11.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 04.11.1996 | Examination requested [1997/11] | 27.09.1999 | Despatch of a communication from the examining division (Time limit: M04) | 22.12.1999 | Reply to a communication from the examining division | 17.03.2000 | Despatch of a communication from the examining division (Time limit: M04) | 12.07.2000 | Reply to a communication from the examining division | 15.01.2001 | Despatch of communication of intention to grant (Approval: Yes) | 30.03.2001 | Communication of intention to grant the patent | 10.05.2001 | Fee for grant paid | 10.05.2001 | Fee for publishing/printing paid | Opposition(s) | 01.08.2002 | No opposition filed within time limit [2002/43] | Fees paid | Renewal fee | 12.05.1997 | Renewal fee patent year 03 | 11.05.1998 | Renewal fee patent year 04 | 12.05.1999 | Renewal fee patent year 05 | 15.05.2000 | Renewal fee patent year 06 | 14.05.2001 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO9317665 (SIEVERS ROBERT E [US], et al) [A] 1-16 * claims 1,8,11 * * page 7, line 7 - line 18 ** page 8, line 3 - line 6 * | [A] - AINGE, G.; ET AL., "Lack of deleterious effects of corticosteroid sprays containing benzalkonium chloride on nasal ciliated epithelium", DRUG INVESTIGATION, (1994), vol. 8, no. 3, pages 127 - 133 [A] 1-16 * the whole document * | [A] - SCADDING, G.K.; ET AL., "clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis", RHINOLOGY, (1991), vol. 11, pages 37 - 43 [A] 1-16 * the whole document * |